So Many Options Coming! What Differences Do We See So Far?

By Cecelia Koetting, OD, and Jade Coats, OD

VUITY: Considerations in the Prescribing of Presbyopia Drops

By Gina M. Wesley, OD

VUITY: Evaluating the New Pharmacologic Presbyopia Treatment Option

By George O. Waring IV, MD

VUITY: What We Have Learned So Far

By Rachael Wruble, OD

Presbyopia-correcting drops may benefit a broad swath of patients.

Pathogenesis of Presbyopia: A New Understanding of an Age-Old Disease

By AnnMarie Hipsley, DPT, PhD, and Max Colbert, MD, MBA

The Progressive Presbyopia Problem

Presbyopia by the Numbers: Who Is Affected by It?

By Komal Patel, OD, Elaine Petry, OD, and Nate Lighthizer, OD

Gaining the Loyalty of the Presbyopic Emmetrope

By David Kading, OD

The Five Pillars of Wellness

By Laura M. Periman, MD

Addressing age-related decreases in functional reserve to maintain optimal eye health

An Evidence Based Guide to Retinal Complications and Miotics

By Cindy Shan, OD, and Carolyn Majcher, OD

Customization of Care

By Elizabeth Yeu, MD

Ophthalmology innovator James V. Mazzo discusses refractive IOLs and other opportunities in presbyopia treatment.

Modernizing Monovision

By Elizabeth Yeu, MD

Getting Current on Corneal Allogenic Lenticules

By John D. Gelles, OD, Steven A. Greenstein, MD, and Peter S. Hersh, MD

New advances make this presbyopia solution an attractive option